Diabetes in America is the NIDDK’s compilation and assessment of epidemiologic, public health, clinical research, and clinical trial data focused on diabetes, its complications and treatment, health care utilization, and diabetes prevention in the United States. These data are intended to be a valuable resource for the research community, clinicians, policy makers, and individuals with diabetes, as well as their caregivers and family members.
There have been three printed editions of Diabetes in America. It was first published in 1984; the second and third editions were published in 1995 and 2018, respectively. The third edition is also available on the National Center for Biotechnology Information, National Library of Medicine’s (NLM) Bookshelf, which expands access to the scientific community through its link to PubMed®.
Diabetes in America has been migrated to an exclusively digital format. Each updated or new article will be available in this Report and on NLM’s Bookshelf. It will also be indexed in PubMed. This was done to remain dynamic as scientific knowledge related to diabetes advances.
Diabetes in America is organized into four broad topic areas.
Section I: Spectrum of Diabetes. Provides descriptive epidemiology of diabetes in the United States based on national surveys and community-based studies, including prevalence estimates and incidence rates; sociodemographic, metabolic, and lifestyle characteristics; risk factors for developing diabetes; and unique aspects of diabetes in selected populations.
Section II: Complications of Diabetes and Related Conditions. Reviews the complications that affect people with diabetes, including mortality.
Section III: Medical Care for Diabetes. Describes diabetes medication use and self-care practices, health care utilization, and quality of care; and economic aspects including health insurance and health care costs for people with diabetes.
Section IV: Prevention of Diabetes. Presents the results of clinical trials and other intervention studies that focus on the prevention of diabetes.
View Publication
Diabetes in America
Table of Contents
Editors:
Jean M. Lawrence, ScD, MPH, MSSA, Sarah Stark Casagrande, PhD, William H. Herman, MD, Deborah J. Wexler, MD, and William T. Cefalu, MD.
Section I: Spectrum of Diabetes
Barbara H. Braffett, PhD, Tessa Crume, PhD, Petter Bjornstad, MD, and Dana Dabelea, MD, PhD
Lauren M. Mitchell, MD, MS, Megan Huisingh-Scheetz, MD, MPH, and Elbert S. Huang, MD, MPH
Maria J. Redondo, MD, PhD, MPH, Suna Onengut-Gumuscu, PhD, and Kyle J. Gaulton, PhD
Raymond J. Kreienkamp, MD, PhD, Benjamin F. Voight, PhD, Anna L. Gloyn, DPhil, and Miriam S. Udler, MD, PhD
PMID: 38117925
Rachel G. Miller, PhD, Dianna J. Magliano, PhD, Nicholas J. Thomas, MD, and Tina Costacou, PhD
PMID: 38117928
Sarah S. Casagrande, PhD and Tiffany L. Gary-Webb, PhD, MHS
Section II: Complications of Diabetes and Related Conditions
Scott J. Pilla, MD, MHS, Mary R. Rooney, PhD, MPH, and Rozalina G. McCoy, MD, MS
PMID: 38117924
PMID: 41812007
PMID: 39571058
Constance E. Ruhl, MD, PhD, Fasiha Kanwal, MD, MSHS, and Aynur Unalp-Arida, MD, PhD
Sarah S. Jaser, PhD, McKenzie K. Roddy, PhD, and Aislinn B. Beam, PhD
Chen Chen, PhD, Wen Ye, PhD, Christopher Becker, MD, Shihchen Kuo, RPh, PhD, Lewis B. Morgenstern, MD, and Lynda D. Lisabeth, PhD
Section III: Medical Care for Diabetes
PMID: 38117923
PMID: 39298640
PMID: 38696642
PMID: 40063710
Section IV: Prevention of Diabetes
PMID: 38843373
PMID: 41284805
Diabetes in America is in the public domain of the United States. You may use the work without restriction in the United States.